(Q51021305)

English

Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.

scientific article published in April 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

atrial fibrillation

0 references

author name string

Lip GY

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

Lowe GD

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

Rumley A

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

Dunn FG

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

language of work or name

0 references

publication date

1 April 1996

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

131

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

724-730

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

Coronary heart disease and atrial fibrillation: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Embolic complications in paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Cerebral computed tomography in paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Significance of atrial fibrillation as a precursor of embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Clinical features of paroxysmal atrial fibrillation an observation of 94 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Thromboembolic complications in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Thromboembolic complications of atrial fibrillation and their prevention: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Atrial fibrillation revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Spontaneous echo contrast in the left atrium during paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Fibrin D-dimer: a useful clinical marker of thrombogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Embolism in Sinoatrial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Systemic Embolism in Chronic Sinoatrial Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Increased intracardiovascular clotting in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Measurement of crosslinked fibrin derivatives in patients undergoing abdominal surgery: use in the diagnosis of postoperative venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990278-1

7 January 2021

Identifiers

10.1016/S0002-8703(96)90278-1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/8721646

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51021305&oldid=1371317518"